Rinostop nasal spray. dosage. 0.05% fl. 15ml # 1

Latin name

Rinostop

Release form

Nasal spray

Packaging

Bottle 15 ml.

pharmachologic effect

Rinostop is a vasoconstrictor for topical use in ENT practice.

Alpha adrenergic agonist.

When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease.

With rhinitis, it facilitates nasal breathing.

Pharmacokinetics

When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.

Indications

Acute allergic rhinitis, sinusitis, hay fever, otitis media (to reduce swelling of the nasopharyngeal mucosa), preparing the patient for diagnostic procedures in the nasal passages.

Contraindications

Angle-closure glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, severe atherosclerosis, hyperthyroidism, surgery on the meninges (in history), hypersensitivity to xylometazoline.

Application during pregnancy and lactation

During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and the fetus, it is not allowed to exceed the recommended doses.

Structure

1 ml spray contains:

Active substance: xylometazoline.

Method of administration and dosage

Intranasally.

Spraying is performed after removing the safety cap from the sprayer.

The nebulizer is inserted into the nose and, by pressing on its base, spray for 1 second.

For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough

should not be applied more than 3 times a day.

For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day

should not be applied more than 3 times a day.

Do not use the drug without interruption for more than 3-5 days.

Side effects

With frequent and / or prolonged use: mucosal irritation, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.

Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, cardiac arrhythmias, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.

With long-term use in high doses: depressive state.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 В° C.

Shelf life

3 years

Dosage

0.05% x 15ml

Structure

1 ml spray contains: Active substance: xylometazoline.

Indications

acute respiratory diseases with symptoms of rhinitis (rhinitis)

acute allergic rhinitis

sinusitis

otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa)

preparation of the patient for diagnostic manipulations in the nasal passages.

INN / Active ingredient

Xylometazoline

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

Contraindications

arterial hypertension

tachycardia

severe atherosclerosis

glaucoma

atrophic rhinitis

surgical interventions on the meninges (in history)

condition after transsphenoidal hypophysectomy

pregnancy

children under 2 years of age (for Rinostop 0.05%)

children under 6 years of age (for the drug Rinostop 0.1%)

hypersensitivity to xylometazoline and other components of the drug.

The drug should be prescribed with caution in diabetes mellitus, hyperthyroidism, pheochromocytoma, diseases of the cardiovascular system (including coronary artery disease), prostatic hyperplasia, during lactation, in patients with hypersensitivity to adrenomimetics, accompanied by insomnia and dizziness.

Specifications

Category

Runny nose

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Virology

Vacation conditions

Without recipe

Volume, ml.

15 ml

Brand name

OTCPharm

Components

activator with protective cap

The amount of the dosage form in the primary package

15 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant - alpha adrenergic agonist

Anatomical and therapeutic characteristics

R01AA07 Xylometazoline

Dosage form

Nasal spray

The target audience

Children

Expiration date in days

730

Dosage (volume) of the substance in the preparation

0.5 mg

Package weight, g

thirty

Mode of application

:

Intranasal. < br> < br> Spraying is performed after removing the protective cap from the nebulizer. < br> < br> The nebulizer is inserted into the nose and, pressing on its base, spray for 1 second. < br> < br> For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough

should not be applied more than 3 times a day. < br> < br> For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day

should not be used more than 3 times a day. < br> Do not use the drug without interruption for more than 3-5 days.

Information on technical characteristics, delivery set, country of manufacture